Search Results

Rugulosin 1 mg  | >95%

AdipoGen Life Sciences

Antibiotic. Antibacteriophage. Antiviral. Mycotoxin. DNA replication, transcription and repair inhibitor. Antibacterial. RNA polymerase and ribonuclease H inhibitor. Insecticidal. Cytotoxic. HIV-1 integrase inhibitor. Shows anti-MRSA (methicillin-resistant Staphylococcus aureus) activity. Potential Hsp90 inhibitor through interacting with N-Hsp90.

More Information Supplier Page

Rugulosin 250 µg  | >95%

AdipoGen Life Sciences

Antibiotic. Antibacteriophage. Antiviral. Mycotoxin. DNA replication, transcription and repair inhibitor. Antibacterial. RNA polymerase and ribonuclease H inhibitor. Insecticidal. Cytotoxic. HIV-1 integrase inhibitor. Shows anti-MRSA (methicillin-resistant Staphylococcus aureus) activity. Potential Hsp90 inhibitor through interacting with N-Hsp90.

More Information Supplier Page

Pyridoxatin 1 mg  | >95%

AdipoGen Life Sciences

Antibiotic. Free radical scavenger. Lipid peroxidation inhibitor. Antimicrobial activity against Candida albicans. Gelatinase A (MMP-2) inhibitor. Anticancer. Cytotoxic. DNA synthesis inhibitor.

More Information Supplier Page

Cercosporin 5 mg  | >95%

AdipoGen Life Sciences

Phytotoxin. Potent and specific PKC inhibitor. Competes for the phorbol binding site. Anticancer compound. Cytotoxic. Antiproliferative. Antiparasitic. Antimicrobial.

More Information Supplier Page

Cercosporin 5 mg  | ≥98%

AdipoGen Life Sciences

Phytotoxin. Potent and specific PKC inhibitor. Competes for the phorbol binding site. Anticancer compound. Cytotoxic. Antiproliferative. Antiparasitic. Antimicrobial.

More Information Supplier Page

Amidepsine D 2.5 mg  | >95%

AdipoGen Life Sciences

Diacylglycerol acyltransferase (DGAT) inhibitor. Excessive accumulation of triacetylglycerol produced by DGAT may cause fatty liver, obesity and hypertriglyceridemia, which may lead to atherosclerosis, diabetes and metabolic disorders.

More Information Supplier Page

Amidepsine D 1 mg  | >95%

AdipoGen Life Sciences

Diacylglycerol acyltransferase (DGAT) inhibitor. Excessive accumulation of triacetylglycerol produced by DGAT may cause fatty liver, obesity and hypertriglyceridemia, which may lead to atherosclerosis, diabetes and metabolic disorders.

More Information Supplier Page

Amidepsine A 2.5 mg  | >95%

AdipoGen Life Sciences

Diacylglycerol acyltransferase (DGAT) inhibitor. Excessive accumulation of triacetylglycerol produced by DGAT may cause fatty liver, obesity and hypertriglyceridemia, which may lead to atherosclerosis, diabetes and metabolic disorders.

More Information Supplier Page

Amidepsine A 1 mg  | >95%

AdipoGen Life Sciences

Diacylglycerol acyltransferase (DGAT) inhibitor. Excessive accumulation of triacetylglycerol produced by DGAT may cause fatty liver, obesity and hypertriglyceridemia, which may lead to atherosclerosis, diabetes and metabolic disorders.

More Information Supplier Page